GL1X · GenesisL1 explorer

Research workbench

Crystal structure of equine serum albumin in complex with diclofenac and naproxen

Analyse Crystal structure of equine serum albumin in complex with diclofenac and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ZBR
Type
protein
Length
580 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Serum albumin
UniProt
F7BAY6
Ligands
NPS, LMR, DIF
Pockets
8 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerum albuminprotein58074% helix, 0% strandF7BAY6

Ligands and binding sites

  • NPS · (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid · ligand · 2 copies · chains A
  • LMR · (2S)-2-hydroxybutanedioic acid · ligand · 2 copies · chains A
  • DIF · 2-[2,6-dichlorophenyl)amino]benzeneacetic acid · ligand · chains A
  • ACT · Acetate ion · additive · 2 copies · chains A
  • FMT · Formic acid · additive · 2 copies · chains A
  • SIN · Succinic acid · additive · chains A
  • MLI · Malonate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15250.810.8765SIN, LMR
27830.790.8256LMR, ACT, FMT
32520.680.8441DIF, NPS
42280.600.8025NPS, MLI
5580.580.9021FMT

Modifications

Observed in the structure: 17 disulfide (disulfide).

Compared structures

  • 4ZBR · Crystal Structure of Equine Serum Albumin in complex with Diclofenac and Naproxen · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.